Isradipine (versus exposed to other treatments)

Exposed non-exposed, cohort studies

Study Country
Study period
Study design
Data source Exposure definition Non-exposure definition Exposition period Sample size
(exposed/unexposed) Or (case / control)
Remarks Risk of bias
Darcie
2004
Brazil
1994 - 1997
prospective cohort
A randomized, longitudinal, prospective study conducting at the Neonatal Pediatrics Service, Faculty of Medicine, University of São Paulo. Newborns of hypertensive mothers treated with isradipine (5 mg twice a day) for at least 2 weeks before the delivery. exposed to other treatment, sick
Newborns of hypertensive mothers treated with atenolol (50 mg twice a day) for at least 2 weeks before the delivery.
late pregnancy 39 / 40 Study considered as a prospective cohort because no precision indicating that a randomization was carried out.
This was a randomized, longitudinal, prospective study comparing 3 groups of patients according to the type of maternal treatment. => Not otherwise specified => Considered as a prospective cohort because no precision indicating that a randomization was carried out.

Case-control studies

Study Country
Study period
Study design
Data source Case Control Exposition Exposition period Sample size
(exposed/unexposed) Or (case / control)
Remarks Risk of bias

Risk of bias: : NA;   : low;   : moderate;   : serious;   : critical;   : unclear;  

Empty. There are no case-control studies available for this drug.

master protocol